ArticleProceedings (Baylor University. Medical Center)2025

Efficacy and safety of nirsevimab for preventing respiratory syncytial virus infection in infants: an updated systematic review and meta-analysis encompassing 11,001 participants.

Mohammad Tanashat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.